<Emphasis Type="Italic">Aconitum</Emphasis> biotechnology: recent trends and emerging perspectives

The genus Aconitum (consists more than 250 species) is one of the most important clades of highly valued medicinal plants. Aconitum species are very essential in the traditional device of medication and feature excessive business demand in the herbal marketplace. Some of biologically energetic compounds, e.g., aconitine, indaconitine, pseudoacontine, and so on, had been recognized, and new formulations primarily based on those compounds are being produced as rapid rate. This has led to extensive and rather unregulated exploitation of the species in the wild making the genus a threatened group. Conventional breeding and propagation methods have contributed significantly, but these could not meet up with the ever increasing demands of herbal drug industry globally. Biotechnological interventions, therefore, emerge as an alternative approach in terms of higher production and conservation as well. In recent years, several reports have been published on in vitro propagation of various important Aconitum species. However, advanced biotechnological approaches, such as synthetic seed production and hairy root cultures, are still lacking with only a few reports available. The current review presents an updated overview and critical assessment of secondary data concerning the past and recent biotechnological approaches and interventions in genus Aconitum. This review also attempts to provide a detailed account of work explored so far in micropropagation and emphasizes over the areas not attempted yet, which will act as a baseline data as well as valuable information for different stakeholders and researchers working on various aspects of Aconitum biotechnology.     

Kinesins in the Arabidopsis genome: A comparative analysis among eukaryotes

Background  

Receptor protein tyrosine phosphatase rho (RPTPρ, gene symbol PTPRT) is a member of the type IIB RPTP family. These transmembrane molecules have been linked to signal transduction, cell adhesion and neurite extension. The extracellular segment contains MAM, Ig-like and fibronectin type III domains, and the intracellular segment contains two phosphatase domains. The human RPTPρ gene is located on chromosome 20q12-13.1, and the mouse gene is located on a syntenic region of chromosome 2. RPTPρ expression is restricted to the central nervous system.